Literature DB >> 8082300

Cytotoxic effects of antibodies to proteinase 3 (C-ANCA) on human endothelial cells.

W J Mayet1, A Schwarting, K H Meyer zum Büschenfelde.   

Abstract

Autoantibodies directed against cytoplasmic antigens of neutrophils (ANCA), especially those with specificity for proteinase 3 (PR-3) and myeloperoxidase, are valuable markers for differential diagnosis and monitoring of disease activity in Wegener's granulomatosis (WG) and other vasculitides. Till now, several concepts concerning a direct role of antibodies against PR-3 in the pathogenesis of WG have been discussed. Recently we were able to show that these antibodies recognize PR-3 translocated into the membrane of human endothelial cells. The aim of this study was to investigate putative cytotoxic effects of antibodies to PR-3 on human endothelial cells. Antibodies were obtained by affinity purification of sera from patients with active WG. Purified antibodies to Ro (SS-A), La (SS-B) and RNP served as controls. Purified antibodies to PR-3 displayed a lytic activity against endothelial cells treated with tumour necrosis factor-alpha (TNF-alpha) with the help of cytokine-primed neutrophils as measured in a Cr-release assay. About 100% specific cytotoxicity occurred after 4 h and was independent of complement. Cytotoxic effects were inhibited by coincubation with unprimed neutrophils or preincubation of PR-3 antibodies with purified antigen. Antibodies to Ro (SS-A), La (SS-B) or RNP had no cytotoxic effect. In summary, PR-3 antibody-induced cytotoxicity required (i) expression of PR-3 on the surface of TNF-alpha-treated endothelial cells; and (ii) co-cultivation of cytokine-primed neutrophils. This is to the best of our knowledge the first report on direct cytotoxic effects of PR-3 antibodies on vascular endothelium. Our data give a hint at a PR-3 antibody-mediated mechanism of endothelial injury via antibody-dependent cellular cytotoxicity in WG and other ANCA-related vasculitides.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8082300      PMCID: PMC1534840          DOI: 10.1111/j.1365-2249.1994.tb06110.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  38 in total

1.  Methods for the detection of anti-endothelial antibodies by enzyme-linked immunosorbent assay.

Authors:  A H Heurkens; A Gorter; T M de Vreede; C S Edgell; F C Breedveld; M R Daha
Journal:  J Immunol Methods       Date:  1991-07-26       Impact factor: 2.303

2.  In vitro production of anti-neutrophilocyte-cytoplasm-antibodies (ANCA) by Epstein-Barr virus-transformed B-cell lines in Wegener's granulomatosis.

Authors:  W J Mayet; E Hermann; B Kiefer; H Lehmann; M Manns; K H Meyer zum Büschenfelde
Journal:  Autoimmunity       Date:  1991       Impact factor: 2.815

Review 3.  Antineutrophil cytoplasmic autoantibodies: a review of the antigens involved, the assays, and the clinical and possible pathogenetic consequences.

Authors:  E C Hagen; B E Ballieux; L A van Es; M R Daha; F J van der Woude
Journal:  Blood       Date:  1993-04-15       Impact factor: 22.113

4.  Antibodies to cathepsin G in Crohn's disease.

Authors:  W J Mayet; E Hermann; J Finsterwalder; H Rieder; T Poralla; K H Meyer Zum Büschenfelde
Journal:  Eur J Clin Invest       Date:  1992-06       Impact factor: 4.686

5.  Antibodies to proteinase 3 increase adhesion of neutrophils to human endothelial cells.

Authors:  W J Mayet; K H Meyer zum Büschenfelde
Journal:  Clin Exp Immunol       Date:  1993-12       Impact factor: 4.330

6.  Antibodies against granule proteins activate neutrophils in vitro.

Authors:  L A Charles; M L Caldas; R J Falk; R S Terrell; J C Jennette
Journal:  J Leukoc Biol       Date:  1991-12       Impact factor: 4.962

7.  Human endothelial cells express proteinase 3, the target antigen of anticytoplasmic antibodies in Wegener's granulomatosis.

Authors:  W J Mayet; E Csernok; C Szymkowiak; W L Gross; K H Meyer zum Büschenfelde
Journal:  Blood       Date:  1993-08-15       Impact factor: 22.113

8.  Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria.

Authors:  E A Jaffe; R L Nachman; C G Becker; C R Minick
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

9.  Autoantibodies developing to myeloperoxidase and proteinase 3 in systemic vasculitis stimulate neutrophil cytotoxicity toward cultured endothelial cells.

Authors:  C O Savage; B E Pottinger; G Gaskin; C D Pusey; J D Pearson
Journal:  Am J Pathol       Date:  1992-08       Impact factor: 4.307

Review 10.  ANCA and associated diseases: immunodiagnostic and pathogenetic aspects.

Authors:  W L Gross; W H Schmitt; E Csernok
Journal:  Clin Exp Immunol       Date:  1993-01       Impact factor: 4.330

View more
  13 in total

Review 1.  Rare diseases.3: Wegener's granulomatosis.

Authors:  C A Langford; G S Hoffman
Journal:  Thorax       Date:  1999-07       Impact factor: 9.139

Review 2.  Small vessel vasculitis of the lung.

Authors:  M I Schwarz; K K Brown
Journal:  Thorax       Date:  2000-06       Impact factor: 9.139

3.  Drug-induced neutropenia associated with anti-neutrophil cytoplasmic antibodies (ANCA): possible involvement of complement in granulocyte cytotoxicity.

Authors:  T Akamizu; S Ozaki; H Hiratani; H Uesugi; J Sobajima; Y Hataya; N Kanamoto; M Saijo; Y Hattori; K Moriyama; K Ohmori; K Nakao
Journal:  Clin Exp Immunol       Date:  2002-01       Impact factor: 4.330

Review 4.  Role of proteinase 3 in activation of endothelium.

Authors:  M E Taekema-Roelvink; C van Kooten; C A Verburgh; M R Daha
Journal:  Springer Semin Immunopathol       Date:  2001

5.  Antineutrophil cytoplasmic antibody and vasculitis: much more than a disease marker.

Authors:  Vivette D'Agati
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

Review 6.  ANCA--pathophysiology revisited.

Authors:  C G Kallenberg; E Brouwer; A H Mulder; C A Stegeman; J J Weening; J W Tervaert
Journal:  Clin Exp Immunol       Date:  1995-04       Impact factor: 4.330

Review 7.  Functional properties of antiendothelial cell antibodies.

Authors:  A Kollmeier; M Kreditor; J George; Y Levy; Y Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  1998       Impact factor: 8.667

8.  Anti-proteinase-3 (PR3) antibodies (C-ANCA) recognize various targets on the human umbilical vein endothelial cell (HUVEC) membrane.

Authors:  M De Bandt; O Meyer; L Dacosta; C Elbim; C Pasquier
Journal:  Clin Exp Immunol       Date:  1999-02       Impact factor: 4.330

9.  C-ANCA-positive IgG fraction from patients with Wegener's granulomatosis induces lung vasculitis in rats.

Authors:  W Weidebach; V S T Viana; E P Leon; C Bueno; A S Leme; F M Arantes-Costa; M A Martins; P H N Saldiva; E Bonfa
Journal:  Clin Exp Immunol       Date:  2002-07       Impact factor: 4.330

Review 10.  Wegener's granulomatosis: a model of auto-antibodies in mucosal autoimmunity.

Authors:  James M Kelley; Jeffrey C Edberg; Robert P Kimberly
Journal:  Clin Immunol       Date:  2009-05-23       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.